Journal of Clinical Epidemiology
Volume 49, Issue 12 , Pages 1459-1466 , December 1996

Deaths from asthma in Italy (1974–1988): Is there a relationship with changing pharmacological approaches?

  • Flaminio Mormile

      Affiliations

    • Corresponding Author InformationAddress reprint requests to: Flaminio Mormile, Clinical Respiratory Physiology, Università Cattolica del Sacro Cuore, Rome, Italy.
    • Clinical Respiratory Physiology, Università Cattolica Del Sacro Cuore, Rome, Italy
    • ,
  • Fabrizio Chiappini

      Affiliations

    • Clinical Respiratory Physiology, Università Cattolica Del Sacro Cuore, Rome, Italy
    • ,
  • Giuseppe Feola

      Affiliations

    • Istituto Nazionale Di Statistica — Istat, Rome, Italy
    • ,
  • Giuliano Ciappi

      Affiliations

    • Clinical Respiratory Physiology, Università Cattolica Del Sacro Cuore, Rome, Italy

,Accepted 17 January 1996.

References 

  1. Stellman JL, Spicer JE, Cayton RM. Morbidity from chronic asthma. Thorax. 1982;37:218–221
  2. Speight ANP, Lee DA, Hey EN. Underdiagnosis and undertreatment of asthma in childhood. Br Med J. 1983;286:1253–1256
  3. Huber HL, Koessler KK. The pathology of bronchial astham. Arch Intern Med. 1922;30:689–760
  4. Jackson RT, Beaglehole R, Rea HH, Sutherland DC. Mortality from asthma: A new epidemic in New Zealand. Br Med J. 1982;285:771–774
  5. Sly MR. Increases in death from asthma. Ann Allergy. 1984;53:20
  6. Sears MR, Rea HH, Beaglehole R, et al.  Asthma mortality in New Zealand: A two-year national study. NZ Med J. 1985;98:271–275
  7. Jackson R, Sears MR, Beaglehole R, Rea H. International trends in asthma mortality: 1970 to 1985. Chest. 1988;94:914–918
  8. Bousquet J, Hatton F, Godard P, Michel B. Asthma mortality in France. J Allergy Clin Immunol. 1987;80:389–394
  9. Sears MR, Beaglehole R. Asthma morbidity and mortality: New Zealand. J Allergy Clin Immunol. 1987;80:383–388
  10. Musk AW, Ryan GF, Perera DM, et al.  Mortality from asthma in western Australia. Med J Aust. 1987;147:423–427
  11. Robin ED. Death from bronchial asthma. Chest. 1988;93:614–618
  12. Burney P. Asthma deaths in England and Wales 1931–1985: Evidence for a true increase in asthma mortality. J Epidemiol Community Health. 1988;42:316–320
  13. Tsai SP, Wen CP. Mortality trends in a rapidly developing economy in Taiwan. I. Comparison with the U.S.A. and Japan. Asia Pac J Public Health. 1989;3:41–50
  14. Klebba A, Scott JH. Estimates of selected comparability ratios based on dual coding of 1976 deaths certificates by the eighth and ninth revisions of the International Classification of Diseases. DHEW Publication No. (PHS) 80-1120. Feb 29, 1980;Vol. 28(No. 11): suppl.
  15. Stewart CJ, Nunn AJ. Are asthma mortality rates changing?. Br J Dis Chest. 1985;79:229–234
  16. Sears MR. Increasing asthma mortality. Fact or artifact?. J Allergy Clin Immunol. 1988;82:957–960
  17. Sears MR, Rea HH, De Boer G, Beaglehole R, et al.  Accuracy of certification of death due to asthma: A national study. Am J Epidemiol. 1986;124:1004–1011
  18. Buist AS. Asthma mortality: What have we learned. J Allergy Clin Immunol. 1989;84:274–283
  19. Marcer G, Bernardi G, Mastrangelo G, Saia B. Mortalità per asma bronchiale in Italia. Folia Allergol Immunol Clin. 1988;35:381–388
  20. La Vecchia C, Fasoli M, Negri E, Tognoni G. Fall and rise in asthma mortality in Italy, 1968–1984. Int J Epidemiol. 1989;18:998–999
  21. Rea HH, Scagg R, Jackson R, et al.  A case control study of deaths from asthma. Thorax. 1986;41:833–839
  22. Woolcock AJ. Worldwide differences in asthma prevalence and mortality. Why is asthma mortality so low in the USA?. Chest. 1986;90:40S–45S
  23. Friday GA, Fireman P. Morbidity and mortality of asthma. Pediatr Clin N Am. 1988;35:1149–1162
  24. Speizer FE, Doll R, Heaf P, Strang LB. An investigation into use of drugs preceding death from asthma. Br Med J. 1968;1:339–343
  25. Stolley PD. Asthma mortality: Why the United States was spared an epidemic of deaths due to asthma. Am Rev Respir Dis. 1972;105:883–890
  26. Stilley PD, Schinnar R. Association between asthma mortality and isoproterenol aerosols: A review. Prev Med. 1978;7:519–538
  27. Wilson JD, Sutherland DC, Thomas AC. Has the change to betaagonists combined with oral theophylline increased cases of fatal asthma?. Lancet. 1981;1:1235–1237
  28. Sly MR. Effects of treatment on mortality from asthma. Ann Allergy. 1986;56:207
  29. Mitchell EA. Is current treatment increasing asthma mortality and morbidity?. Thorax. 1989;44:81–84
  30. Crane J, Pearce N, Flatt A, Burgess C, Jackson R, Kwong T, et al. Prescribed fenoterol and death from asthma in New Zealand, 1981–1983. Case-control study. Lancet. 1989;1:917–922
  31. Grant IW. Has the change to beta-agonists combined with oral theophylline increased cases of fatal asthma?. Lancet. 1981;2:36–37
  32. Istituto Centrale di Statistica . Classificazioni delle Malattie, Traumatismi e Cause di Morte. 9th revision Metodi e Norme Serie C, No. 10. 1975;Vol. 1:
  33. Barger LW, Vollmer WM, Felt R, Buist AS. Further investigation into the recent increase in asthma deaths: A review of 41 asthma deaths on Oregon in 1982. Ann Allergy. 1988;60:31–40
  34. Riou B, Barriot P. Accuracy in asthma mortality in France. Chest. 1990;97:507–509 (Letter)
  35. Rackemann M, Edwards MC. Asthma in children: A follow-up study of 688 patients after an interval of twenty years. N Engl J Med. 1952;246:815–823
  36. Ogilvie AG. Asthma: A study in prognosis of 1,000 patients. Thorax. 1962;17:183–189
  37. Blair H. Natural history of childhood asthma: 20-year follow-up. Arch Dis Child. 1977;613–619
  38. Anderson M, Loy RM. Mortality from respiratory disease at follow-up of patients with asthma. Br J Dis Chest. 1977;71:198–202
  39. Paoletti P, Cangiani G, Viegi G, et al.  Prevalence of asthma and asthma symptoms in a general population in north Italy. Eur Resp J. 1989;2(Suppl. 6):527s–531s
  40. Bullen SS. Correlation of clinical and autopsy findings in 176 cases of asthma. J Allergy. 1952;23:193–203
  41. Braman SS, Kaemmerlen JT, Davis SM. Asthma in the elderly. A comparison between patients with recently acquired and long-standing disease. Am Rev Respir Dis. 1991;143:336–340
  42. Weiss KB. Seasonal trends in US asthma hospitalizations and mortality. JAMA. 1990;263:2323–2328
  43. British Thoracic Society . Comparison of atopic and non-atopic patients dying of asthma. Br J Dis Chest. 1987;81:30–35
  44. McDonald JB, Seaton A, Williams DA. Asthma deaths in Cardiff 1963–1974: 90 deaths outside hospital.. Br Med J. 1976;1:1493–1495
  45. Wasserfallen JB, Schaller MD, Feihl F, Perret CH. Sudden asphyxic asthma: A distinct entity?. Am Rev Respir Dis. 1990;142:108–111
  46. Juel K, Pedersen PA. Increasing asthma mortality in Denmark 1969–1988 not a result of a changed coding practice. Ann Allergy. 1992;68:180–182
  47. Correman J, Segala C, Henry C, Neukirck F. Mortalité rapportée à l'asthme. Tendances pour la France de 1970 à 1987. Rev Mal Resp. 1992;9:495–501
  48. Asher MI, Pattemore PK, Harrison AC, Mitchell EA, Rea HH, Stewart AW, et al. International comparison of the prevalence of asthma symptoms and bronchial hyperresponsiveness. Am Rev Respir Dis. 1988;138:524–529
  49. Boulet LP, Cartier A, Thomson NC, et al.  Asthma and increase in nonallergic bronchial responsiveness from seasonal pollen exposure. J Allergy Clin Immunol. 1983;71:399–497
  50. Fleming DM, Crombie DL. Prevalence of asthma and hay fever in England and Wales. Br Med J. 1987;294:279–283
  51. Aberg N. Asthma and allergic rhinitis in Swedish conscripts. Clin Exp All. 1989;19:59–63
  52. Wuthrich B. In Switzerland pollinosis has really increased in the last decade.. ACI News. 1991;3:41
  53. Burney PGJ, Britton JR, Chim S, et al.  Descriptive epidemiology of bronchial reactivity in an adult population: Results from a community study. Thorax. 1987;42:38–44
  54. Forastiere F, Pistelli R, Michelozzi P, Corbo G, Agabiti N, Bertollini R, et al. Indices of nonspecific bronchial responsiveness in a pediatric population. Chest. 1991;100:927–934
  55. Viegi G, Baldacci S, Vellutini M, Carozzi L, et al.  Prevalence rates of diagnosis of asthma in general population samples of northern and central Italy. Monaldi Arch Chest Dis. 1994;49:191–196
  56. Viegi G, Fialdini AM, Vellutini M, Carozzi L, et al.  Bronchial rectivity in a general population of northern Italy: Relationships with occupational exposure. Monaldi Arch Chest Dis. 1994;49:15–18
  57. Woolcock AJ. Evolution de la morbidité et de la mortalité de l'asthme dans le monde. Expication de l'evolution. Bull Union Int Tuberc Mal Resp. 1991;66:91–96
  58. Editorial: Bronchial asthma and the environment. Lancet. 1986;2:786
  59. Editorial: Asthma and the weather. Lancet. 1985;1:1079–1080
  60. Burney PGJ. A diet rich in sodium may potentiate asthma: Epidemiological evidence for a new hypothesis. Chest. 1987;91:143S–148S
  61. Sly RM, O'Donnell R. Regional distribution of deaths from asthma. Ann Allergy. 1989;347–354
  62. Ruggieri F, Hindle M. Diagnosis and treatment of asthma across Europe. Eur Respir J. 1989;2(Suppl. 6):536s–539s
  63. Esdaile JM, Feinstein AR, Honvitz R. A reappraisal of the United Kingdom epidemic of fatal asthma. Can general mortality data implicate a therapeutic agent?. Arch Intern Med. 1987;147:543–549
  64. Pearce N, Grainger J, Atkinson M, et al.  Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977–1981. Thorax. 1990;45:170–175
  65. Grainger J, Woodman K, Pearce N, et al.  Prescribed fenoterol and death from asthma in New Zealand, 1981-7: A further case-control study. Thorax. 1991;46:105–111
  66. Spitzer W, Suissa S, Ernst P, et al.  The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med. 1992;326:501–506
  67. Ernst P, Habbick B, Suissa S, Hemmelgarn B, et al.  Is the association between inhaled beta-agonist use and life threatening asthma because of confounding by severity?. Am Rev Respir Dis. 1993;148:75–79
  68. Suissa S, Ernst P, Boivin JF, Horvitz R, et al.  A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonist. Am J Respir Crit Care Med. 1994;149:604–610
  69. Lofdahl CG, Svedmyr N. Beta-agonists—Friends or foes?. Eur Respir J. 1991;1161–1165
  70. Sears MR, Taylor DR, Print CG, et al.  Regular treatment with inhaled beta-agonist in bronchial asthma. Lancet. 1990;336:1391–1396
  71. Hodgkin JE. United States audit of asthma therapy. Chest. 1986;90:62S–66S
  72. Marsac J. French audit of asthma therapy. Chest. 1986;90:78S–80S
  73. Vermeire PA, Wittesaele WM, Janssens E, De Backer WA. European audit of asthma therapy. Chest. 1986;90:58S–61S
  74. Keating G, Mitchell EA, Jackson RT, et al.  Trends in sales of drugs for asthma in New Zealand, Australia, and the United Kingdom, 1975-81. Br Med J. 1984;289:348
  75. Holgate ST, Roche W, Djukanovis R, Wilson J, Britten K, Howarth P. The need for a pathological classification of asthma. Eur Resp J. 1991;4(Suppl. 13):113s–122s
  76. Saetta M, Di Stefano A, Rosina C, Thiene G, Fabbri LM. Quantitative structural analysis of peripheral airways and arteries in sudden fatal asthma. Am Rev Respir Dis. 1991;143:138–143
  77. Sears MR, Rea HH, Rothwell RPG, et al.  Asthma mortality: Comparison between New Zealand and England. Br Med J. 1986;293:1342–1345
  78. Gregg I. Is current treatment increasing asthma mortality and morbidity?. Thorax. 1989;44:686–687
  79. Persson CGA. Xanthines as airway anti-inflammamtory drugs. J Allergy Clin Immunol. 1988;81:615–617
  80. Persson CGA. Some pharmacological aspects of xanthines in asthma. Eur J Respir Dis. 1980;61(Suppl. 109):7
  81. Aubier M, de Troyer A, Sampson M, Macklem PT, Roussos CM. Aminophylline improves diaphragm contractility. N Engl J Med. 1981;305:249–252
  82. Bai TR. Abnotmalities in airway smooth muscle in fatal asthma. Am Rev Respir Dis. 1990;141:552–557
  83. Makino S. Preventive therapy of chronic asthma in Japan. ACI News. 1991;107

PII: S0895-4356(96)00188-6

Journal of Clinical Epidemiology
Volume 49, Issue 12 , Pages 1459-1466 , December 1996

Article Tools